Analytical Data
-
Gene name
Xcl1
- Application
-
Alternative Names
Xcl1；LTN；SCYC1；Lymphotactin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P47992
-
Expression Region
23-114aa
-
AA Sequence
GSEVSDKRTC VSLTTQRLPV SRIKTYTITE GSLRAVIFIT KRGLKVCADP QATWVRDVVR SMDRKSNTRN NMIQTKPTGT QQSTNTAVTL TG
-
Molecular Weight
10.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Xcl1, a member of the C-C chemokine family, plays a crucial role in immune responses and has garnered significant attention in immunological research. Initially identified in the context of T cell differentiation, Xcl1 is primarily produced by activated cytotoxic T cells and dendritic cells, making it vital for modulating immune responses against pathogens and tumors. Its unique ability to attract and activate other immune cells, particularly in the context of viral infections and tumor environments, underscores its importance in shaping adaptive immunity. Various studies have highlighted Xcl1's potential therapeutic applications, particularly in enhancing anti-tumor responses and improving vaccine efficacy. The recombinant Xcl1 protein, therefore, represents a promising tool for scientific exploration, enabling researchers to dissect its functional roles in immune modulation and its interactions with other cytokines. As investigations into the therapeutic implications of Xcl1 continue to expand, understanding its signaling pathways and mechanisms of action will be critical for developing innovative immunotherapies aimed at harnessing the body's immune system to combat diseases more effectively.
